Trials / Conditions / Human Immunodeficiency Virus 1

Human Immunodeficiency Virus 1

4 registered clinical trials studyying Human Immunodeficiency Virus 1.

Status	Trial	Sponsor	Phase
Withdrawn	MK-8510 Monotherapy for the Treatment of Anti-retroviral naïve Human Immunodeficiency Virus Type 1 (HIV-1) Inf NCT05700734	Merck Sharp & Dohme LLC	Phase 1
Completed	A Safety Study to Evaluate the Antiviral Activity of Darunavir in Combination With Ritonavir in HIV 1 Infected NCT00919854	Tibotec Pharmaceuticals, Ireland	Phase 2
Completed	A Study to Compare Brachial Artery Reactivity and Cardiovascular Risk of a Treatment Simplification by Darunav NCT01391013	Janssen-Cilag S.p.A.	Phase 2
Completed	A Pilot Study Of A Novel Treatment Regimen, Maraviroc + Ritonavir Boosted Atazanavir, In Treatment Naive HIV-I NCT00827112	ViiV Healthcare	Phase 2